FibroGen, Inc - Common Stock (NQ:FGEN)

9.710 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about FibroGen, Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Over $1.7M Bet On Globalstar? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗

March 12, 2024

The Dow Jones index closed higher by around 47 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Week In Review: Mabwell Sells Ex-China Rights To Rare Disease Therapy In $412 Million Deal ↗

March 02, 2024

Mabwell, a Shanghai-San Diego biotech, sold ex-China rights for 9MW3011 to Disc Medicine of Watertown, MA in a deal worth up to $412 million. Meanwhile, AstraZeneca has returned most of the global...

Via Talk Markets

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

February 27, 2024

It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news affecting shares on Tuesday morning!

Via InvestorPlace

Recap: FibroGen Q4 Earnings ↗

February 26, 2024

Via Benzinga

FibroGen's Earnings Outlook ↗

February 23, 2024

Via Benzinga

Earnings Scheduled For November 6, 2023 ↗

November 06, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.

Via Benzinga

Expert Ratings for FibroGen ↗

August 08, 2023

Via Benzinga

Preview: FibroGen's Earnings ↗

August 04, 2023

Via Benzinga

Earnings Scheduled For February 26, 2024 ↗

February 26, 2024

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 02, 2024

Via Benzinga

Top 4 Health Care Stocks That May Crash This Quarter ↗

February 02, 2024

As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 29, 2024

Via Benzinga

FIBROGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating FibroGen, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

December 26, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

November 07, 2023

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.

Via Benzinga

7 Stocks to Sell Before the Axe Falls ↗

October 19, 2023

While an uncomfortable topic to discuss, consistent success in the market will require an objective view of stocks to sell.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 30, 2023

Via Benzinga

Why REX American Resources Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

August 30, 2023

Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 89.5% to $2.7852 after the company reported outcomes from a UroShield study conducted at the University of Southampton in the U.K.

Via Benzinga

Gold Moves Higher; Outlook Therapeutics Shares Plummet ↗

August 30, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Wednesday. The Dow traded up 0.14% to 34,900.33 while the NASDAQ rose 0.69% to 14,040.27. The...

Via Benzinga

Topics Stocks

Dow Surges 150 Points; US Economy Grows At 2.1% Pace In Q2 ↗

August 30, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Wednesday. The Dow traded up 0.44% to 35,006.93 while the NASDAQ rose 0.45% to 14,006.86. The S&P 500, also rose,...

Via Benzinga

Topics Economy Stocks

Why NanoVibronix Shares Are Trading Higher By 49%; Here Are 20 Stocks Moving Premarket ↗

August 30, 2023

Gainers AgileThought, Inc. (NASDAQ: AGIL) rose 96.5% to $0.3046 in pre-market trading after falling 17% on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 30, 2023

Via Benzinga

Three In A Row: FibroGen's Investigational Drug Flunks In Another Study For Rare Disease In Young Boys ↗

August 30, 2023

Tuesday, FibroGen Inc (NASDAQ: FGEN) announced topline data from the Phase 3 LELANTOS-2 trial of pamrevlumab for ambulatory patients with Duchenne muscular dystrophy (DMD) on

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 30, 2023

Pre-market stock movers are a hot topic on Wednesday morning and we're covering the shares rising and falling this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 29, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 08, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023 ↗

August 08, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

July 27, 2023

During Thursday, 56 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

July 26, 2023

Wednesday saw 59 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

July 24, 2023

On Monday morning, 70 companies achieved new lows for the year.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.